HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological properties of betabeta-di-methyl-acryloylcholine and some other beta-substituted acryloylcholines.

Abstract
The mammalian pharmacology of a new naturally occurring ester of choline, betabeta-dimethylacryloylcholine (DMAC), has been studied, mainly in the cat, together with that of two synthetic beta-substituted acryloylcholines, crotonoylcholine and pent-2-enoylcholine. Comparisons have been made with the reduced form of DMAC, isovalerylcholine, with another naturally ocurring beta-substituted acryloylcholine, murexine (urocanoylcholine), and with suxamethonium. DMAC has been shown to be a ganglion stimulating and neuromuscular blocking agent generally similar, in potency and properties, to murexine. It is also a powerful respiratory stimulant. The other unsaturated esters behaved similarly but were less potent.
AuthorsB HOLMSTEDT, V P WHITTAKER
JournalBritish journal of pharmacology and chemotherapy (Br J Pharmacol Chemother) Vol. 13 Issue 3 Pg. 308-14 (Sep 1958) ISSN: 0366-0826 [Print] England
PMID13584734 (Publication Type: Journal Article)
Chemical References
  • acryloylcholine
  • murexine
  • Succinylcholine
  • Choline
Topics
  • Animals
  • Cats
  • Choline (analogs & derivatives)
  • Succinylcholine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: